14-day Premium Trial Subscription Try For FreeTry Free
Currently predicting for Mon, 6 May 2024

Trading levels for ARWR

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 25.71 5.18 %
R2 25.28 3.46 %
R1 25.02 2.39 %
Current price: 24.44
Support S1 24.18 -1.07 %
S2 23.92 -2.13 %
S3 23.50 -3.86 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 29.92 22.42 %
R2 29.40 20.29 %
R1 28.28 15.71 %
Current price 24.44
Support S1 23.13 -5.36%
S2 22.61 -7.49%
S3 22.53 -7.82%

ARWR Predictions History

4 years ago
Alan predicted that ARWR for 2019-08-16 is going $29.03 (-6.93%)

5 years ago
NameNotImportant predicted that ARWR for 2019-05-06 is going $18.58 (0.16%)

5 years ago
NameNotImportant predicted that ARWR for 2019-05-01 is going $17.79 (2.07%)

6 years ago
Sunny.Chyun.21972 predicted that ARWR for 2018-03-19 is going $6.24 (-17.13%)

Rank:

6 years ago
David.Smith.22072 predicted that ARWR for 2018-03-19 is going $7.89 (4.78%)

Rank:

6 years ago
Ebunoluwa.James.22076 predicted that ARWR for 2018-03-19 is going $8.00 (6.24%)

Rank:

6 years ago
Moleo.Gharib.15518 predicted that ARWR for 2017-12-18 is going $3.11 (-0.96%)

Rank:

6 years ago
Clint.Gray.15276 predicted that ARWR for 2017-12-18 is going $3.24 (3.18%)

Rank:

6 years ago
JS predicted that ARWR for 2017-12-18 is going $3.12 (-0.64%)

6 years ago
Balagurubaran predicted that ARWR for 2017-12-18 is going $3.18 (1.27%)

Rank:
Click to get the best stock tips daily for free!

About Arrowhead Research Corporation

Arrowhead Research Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, which is in phase 2b and one phase 3 clinical trial to treat hypertriglyceridemia; ARO-ANG3 that is in P... ARWR Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT